483
PMS4PMSFDA 483 - PMS4PMS - November 08, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
PMS4PMS, an OTC manufacturer in Clarence, NY, was cited for significant deficiencies during an FDA inspection from November 4-8, 2024. The firm lacked a quality control unit and failed to implement essential CGMP-compliant quality systems for its Comforte' Menstrual Cramp Relief Cream. Key issues included inadequate product release testing, raw material testing, unsubstantiated expiration dating, and insufficient employee training.
Open in Dashboard
ID · 9a695258-6d59-4153-948e-ceabe634a733